JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258739

Human TTC3 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TTC3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Insertion of the selection cassette in exon2.

View Alternative Names

DCRR1, E3 ubiquitin-protein ligase TTC3, Protein DCRR1, RING finger protein 105, RNF105, TPR repeat protein 3, TPR repeat protein D, TPRD, TPRDI, TPRDII, TPRDIII, TTC3_HUMAN, Tetratricopeptide repeat protein 3, Tetratricopeptide repeat protein 3 (TPR repeat protein D)

1 Images
Sanger Sequencing - Human TTC3 knockout HeLa cell lysate (AB258739)
  • Sanger seq

Unknown

Sanger Sequencing - Human TTC3 knockout HeLa cell lysate (AB258739)

Homozygous : Insertion of the selection cassette in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Insertion of the selection cassette in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258739-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TTC3 knockout HeLa cell lysate", "number":"AB258739-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258739-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TTC3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The TTC3 protein also known as Tetratricopeptide Repeat Domain 3 has a molecular weight of approximately 215 kDa. This protein functions as an E3 ubiquitin-protein ligase which means it plays a role in tagging proteins for degradation via the ubiquitin-proteasome system. TTC3 is widely expressed in the brain especially within neurons and is also found in other tissues such as the heart and kidneys. It contains tetratricopeptide repeats which are known for facilitating protein-protein interactions essential for its role in cellular function and signaling.
Biological function summary

TTC3 interacts in various processes associated with cell development and stability. It is not part of a larger protein complex but operates notably in cell cycle progression and neuronal differentiation. TTC3 regulates the stability of proteins by adding ubiquitin molecules which are small regulatory proteins to target proteins. This activity is important for maintaining the cellular environment especially in tissues where precise control over protein levels is necessary.

Pathways

Many cellular pathways are influenced by TTC3 including the PI3K-AKT signaling pathway which mediates several cellular processes such as growth and survival. TTC3 has connections with proteins such as AKT1 through this pathway which helps regulate cell proliferation and neurogenesis. Additionally TTC3 is involved in the stability regulation of cyclin proteins influencing the cell cycle by interacting with components of the cyclin-dependent kinase (CDK) pathway therefore affecting cell cycle checkpoints and transitions.

Evidence shows that changes in TTC3 expression have links to neurological conditions like Down syndrome and Alzheimer's disease. In these disorders altered TTC3 function affects neuronal growth and function likely through dysregulated ubiquitination processes. Additionally TTC3 interacts with proteins like DYRK1A which is also implicated in neurodegenerative conditions and Down syndrome pathophysiology. Altered TTC3 activity therefore contributes to the molecular mechanisms driving these diseases suggesting its potential as a therapeutic target.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com